Scientists and members of the public exploring the controversial area of U.S. human embryo and embryoid research will find a complex and sometimes bewildering assortment of federal and state laws. The authors recommend additional guidance, but note slow progress in the development of embryo research policy.
Hospital at Home programs offer an alternative care model for acutely ill patients to receive intensive at-home treatment. With better policy and operations, can this model work at scale in the United States beyond the pandemic?
Anaeze C. Offodile II, Celynne Balatbat, Kushal T. Kadakia, Victor DzauAugust 23, 2021
This study leverages validated patient-reported outcomes measures to analyze the association between "financial toxicity" and quality of life and satisfaction among women undergoing ablative breast cancer surgery. Journal of the American College of Surgeons
Anaeze C. Offodile II, Christopher J. Coroneos, Yu-Li Lin, Chris Sidey-Gibbons, Malke Asaad, Brian Chin, Stefanos Boukovalas, Margaret S. Roubaud, Makesha Miggins, Donald P. BaumannDecember 21, 2020
To understand the variations and impact of national policies, the authors reviewed and analyzed IVF, hESC and human embryo research laws or national guidelines currently in place in the top R&D-investing nations. Regenerative Medicine, Aug. 17, 2020.
Kirstin R.W. Matthews, Daniel MoralíAugust 17, 2020